Anavo Therapeutics provides therapeutic potential of human phosphatase biology.
Anavo Therapeutics has raised $9.4M in total funding. The most recent round was Seed. The last funding was announced in May 2023.
Anavo Therapeutics's investors include Inkef, MRL Ventures Fund, Taiho Ventures, M Ventures, Bioqube Ventures.
Anavo Therapeutics is headquartered in Leiden, The Netherlands.
Anavo Therapeutics provides therapeutic potential of human phosphatase biology.
Anavo Therapeutics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Anavo Therapeutics — Funding & Investors." VCBacked, May 2, 2023, https://www.vcbacked.co/company/anavo-therapeutics. Accessed September 15, 2026.
VCBacked. (2023). Anavo Therapeutics — Funding & Investors. Retrieved September 15, 2026, from https://www.vcbacked.co/company/anavo-therapeutics
{{cite web |title=Anavo Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/anavo-therapeutics |website=VCBacked |access-date=September 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated